Figures & data
Figure 2 (A) HREM image of Mn0.5 Zn0.5Fe2O4. (B) SEM-EDS analysis of Mn0.5 Zn0.5Fe2O4. (C) XRD analysis of Mn0.5 Zn0.5Fe2O4. (D) TEM image of the PEI-Mn0.5 Zn0.5Fe2O4. (E) FTIR of PEI- Mn0.5 Zn0.5Fe2O4 and Mn0.5 Zn0.5Fe2O4. (F) Adsorption of PEI on the surface of nanoparticles under different pH. (G) Scheme of PEI/MZF interaction with DNA.
![Figure 2 (A) HREM image of Mn0.5 Zn0.5Fe2O4. (B) SEM-EDS analysis of Mn0.5 Zn0.5Fe2O4. (C) XRD analysis of Mn0.5 Zn0.5Fe2O4. (D) TEM image of the PEI-Mn0.5 Zn0.5Fe2O4. (E) FTIR of PEI- Mn0.5 Zn0.5Fe2O4 and Mn0.5 Zn0.5Fe2O4. (F) Adsorption of PEI on the surface of nanoparticles under different pH. (G) Scheme of PEI/MZF interaction with DNA.](/cms/asset/62db25e2-6313-42ba-84b0-e172b67f074a/dijn_a_334015_f0002_c.jpg)
Table 1 PEI-Mn0.5Zn0.5Fe2O4 Nanoparticle Toxicity Test MTT (, n=8)
Table 2 PEI/DNA Toxicity Test MTT (, n = 8)
Figure 3 Comparison of PEI-MZF and PEI cytotoxicity under different N/P ratio The N/P ratio of PEI/MZF/DNA and PEI/DNA was 1, 3, 5, 7, 9, 11.
![Figure 3 Comparison of PEI-MZF and PEI cytotoxicity under different N/P ratio The N/P ratio of PEI/MZF/DNA and PEI/DNA was 1, 3, 5, 7, 9, 11.](/cms/asset/8bdd856f-c653-4a8b-95f3-6bf453c3ae59/dijn_a_334015_f0003_c.jpg)
Table 3 Hemolysis Test Results
Table 4 Results of Acute Toxicity Test of Nanoparticles
Table 5 Micronucleus Test Results
Figure 5 Image of agarose gel electro-phoresis of plasmid DNA and complexed with PEI- Mn0.5 Zn0.5Fe2O4 (Lane1-5(PEI-MZF/DNA w/w): 0:1; 5:1; 10:1; 20:1; 30:1).
![Figure 5 Image of agarose gel electro-phoresis of plasmid DNA and complexed with PEI- Mn0.5 Zn0.5Fe2O4 (Lane1-5(PEI-MZF/DNA w/w): 0:1; 5:1; 10:1; 20:1; 30:1).](/cms/asset/862de8d3-b5bd-4f13-8dcf-5ba2b69437b6/dijn_a_334015_f0005_b.jpg)
Figure 6 (A) PCR gel electrophoresis of Egr1-HSVTK transfected (lane 1: Marker IV (each band in turn from top to bottom is 7 K, 5.5 K, 3.5 K, 2 K, 1 K, 500 bp); lane 1: Egr1-HSVTK). (B) Sequencing and alignment of Egr1-HSVTK (sequence 0: HSVTK; sequence 1:Egr1-HSVTK-Egr1-f.ab1; software: Dnassit 2.0).
![Figure 6 (A) PCR gel electrophoresis of Egr1-HSVTK transfected (lane 1: Marker IV (each band in turn from top to bottom is 7 K, 5.5 K, 3.5 K, 2 K, 1 K, 500 bp); lane 1: Egr1-HSVTK). (B) Sequencing and alignment of Egr1-HSVTK (sequence 0: HSVTK; sequence 1:Egr1-HSVTK-Egr1-f.ab1; software: Dnassit 2.0).](/cms/asset/a3b1e8ee-a78f-4acb-97ff-a3f9fbc99188/dijn_a_334015_f0006_c.jpg)
Figure 7 (A) PCR gel electrophoresis of Hsp70-Egr1-EGFP transfected (lane 1: Marker IV each band in turn from top to bottom is 7 K, 5.5 K, 3.5 K, 2 K, 1 K, 500 bp); lane 1–4: Hsp70-Egr1-EGFP①-④). (B) Sequencing and alignment of Hsp70-Egr1-EGFP (sequence 0: HSP70; sequence 1: Hsp70-Egr1-EGFP-f.ab1; software: Dnassit 2.0).
![Figure 7 (A) PCR gel electrophoresis of Hsp70-Egr1-EGFP transfected (lane 1: Marker IV each band in turn from top to bottom is 7 K, 5.5 K, 3.5 K, 2 K, 1 K, 500 bp); lane 1–4: Hsp70-Egr1-EGFP①-④). (B) Sequencing and alignment of Hsp70-Egr1-EGFP (sequence 0: HSP70; sequence 1: Hsp70-Egr1-EGFP-f.ab1; software: Dnassit 2.0).](/cms/asset/a33c236d-0598-461c-a8bb-28d52a010d04/dijn_a_334015_f0007_c.jpg)
Figure 8 (A) Egr1-Hsp70- HSVTK was identified by EcoRI and HindIII dual restriction enzyme digestion (lane 1: Marker IV each band in turn from top to bottom is 7 K, 5.5 K, 3.5 K, 2 K, 1 K, 500 bp;lane 1–3: pCDNA3.1-Egr1- Hsp70-HSVTK①-③digested by EcoRI and HindIII.). (B) Egr1- Hsp70-HSVTK was identified by MluI restriction enzyme digestion (lane 1: Marker IV each band in turn from top to bottom is 7 K, 5.5 K, 3.5 K, 2 K, 1 K, 500 bp;lane 1–2: Hsp70-Egr1- HSVTK ①-②digested by MluI.).
![Figure 8 (A) Egr1-Hsp70- HSVTK was identified by EcoRI and HindIII dual restriction enzyme digestion (lane 1: Marker IV each band in turn from top to bottom is 7 K, 5.5 K, 3.5 K, 2 K, 1 K, 500 bp;lane 1–3: pCDNA3.1-Egr1- Hsp70-HSVTK①-③digested by EcoRI and HindIII.). (B) Egr1- Hsp70-HSVTK was identified by MluI restriction enzyme digestion (lane 1: Marker IV each band in turn from top to bottom is 7 K, 5.5 K, 3.5 K, 2 K, 1 K, 500 bp;lane 1–2: Hsp70-Egr1- HSVTK ①-②digested by MluI.).](/cms/asset/12b399a1-3da2-4552-8954-75c684c927a7/dijn_a_334015_f0008_c.jpg)
Figure 9 TK expression induced by radiation at different time point. Compared the TK expression at 48h with that in other groups, P < 0.05. Compared the TK expression at 6h with that at other time point, P < 0.05.
![Figure 9 TK expression induced by radiation at different time point. Compared the TK expression at 48h with that in other groups, P < 0.05. Compared the TK expression at 6h with that at other time point, P < 0.05.](/cms/asset/80e2d381-9a88-41bf-955f-9f9d37b074d0/dijn_a_334015_f0009_b.jpg)
Figure 10 TK expression induced by different dose of radiation. Compared the TK expression with 0Gy radiation with that in other groups P < 0.05. Compared the TK expression after 2Gy radiation with that in other groups P < 0.05.
![Figure 10 TK expression induced by different dose of radiation. Compared the TK expression with 0Gy radiation with that in other groups P < 0.05. Compared the TK expression after 2Gy radiation with that in other groups P < 0.05.](/cms/asset/3faaf1e5-85a9-4462-8898-ae7d72f89ba5/dijn_a_334015_f0010_b.jpg)
Figure 11 TK expression induced by different methods. Compared the TK expression without treatment, with that in other groups P < 0.05. Compared the TK expression with radiation and thermo, with that in other groups P < 0.05.
![Figure 11 TK expression induced by different methods. Compared the TK expression without treatment, with that in other groups P < 0.05. Compared the TK expression with radiation and thermo, with that in other groups P < 0.05.](/cms/asset/cb3ad09d-835d-41e6-bcfa-949db1680a09/dijn_a_334015_f0011_b.jpg)
Figure 12 Expression of HSV-TK in SMC7721cells induced by different methods. 1 100bp Marker. 2 Negative control (not transfected). 3 Radiation group (not transfected). 4 Hyperthermia group (not transfected). 5 TK transfection by radiation induction group. 6 TK transfection by heat induction group. 7 TK transfection by radiation and heat shock induction group.
![Figure 12 Expression of HSV-TK in SMC7721cells induced by different methods. 1 100bp Marker. 2 Negative control (not transfected). 3 Radiation group (not transfected). 4 Hyperthermia group (not transfected). 5 TK transfection by radiation induction group. 6 TK transfection by heat induction group. 7 TK transfection by radiation and heat shock induction group.](/cms/asset/d4f2b188-e58c-4c8d-9535-2846e5711a56/dijn_a_334015_f0012_b.jpg)
Table 6 The Cell Viability of SMMC-7721 cells After Treatment (, n = 6)
Table 7 Flow Cytometry of Cell Cycles and Apoptosis
Figure 14 (A) Cell cycle results of SMMC7721 cells after treatment. (B) Flow cytometry results of SMMC7721 cells after treatment.
![Figure 14 (A) Cell cycle results of SMMC7721 cells after treatment. (B) Flow cytometry results of SMMC7721 cells after treatment.](/cms/asset/96d78e6e-41c6-4966-bce3-e2f533604fd3/dijn_a_334015_f0014_c.jpg)
Figure 15 (A) Inhibitory rate of weight and mass in xenograft tumor after treatment. (B) Tumor morphological appearance after treatment. 1 Negative group. 2 Radiation group. 3 Radiation-gene group. 4 Mn0.5Zn0.5Fe2O4 hyperthermia group. 5 Heat-gene group. 6 The combined group. (C) The histo-morphology of tumors after treatment (100×). Negative group: The cells are tightly arranged, with rich cytoplasm, large and deeply stained nucleus, and active proliferation. Combined group: The cells are obviously necrotic, and magnetic material deposition can be seen between the tissue. (D) The histo-morphology of organs after treatment (100×). A lung B heart C kidney D liver E spleen.
![Figure 15 (A) Inhibitory rate of weight and mass in xenograft tumor after treatment. (B) Tumor morphological appearance after treatment. 1 Negative group. 2 Radiation group. 3 Radiation-gene group. 4 Mn0.5Zn0.5Fe2O4 hyperthermia group. 5 Heat-gene group. 6 The combined group. (C) The histo-morphology of tumors after treatment (100×). Negative group: The cells are tightly arranged, with rich cytoplasm, large and deeply stained nucleus, and active proliferation. Combined group: The cells are obviously necrotic, and magnetic material deposition can be seen between the tissue. (D) The histo-morphology of organs after treatment (100×). A lung B heart C kidney D liver E spleen.](/cms/asset/8efe53c5-c6fb-49c6-a0a0-67585314ffbb/dijn_a_334015_f0015_c.jpg)